Open | $0.610 |
Close | $0.643 |
Volume / Avg. | 14.950K / 37.536K |
Day Range | 0.610 - 0.670 |
52 Wk Range | 0.380 - 1.290 |
Market Cap | $22.891M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.24% |
Days to Cover | 1.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Forte Biosciences (NASDAQ: FBRX) through any online brokerage.
Other companies in Forte Biosciences’s space includes: Galecto (NASDAQ:GLTO), OncoCyte (NASDAQ:OCX), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for Forte Biosciences (NASDAQ: FBRX) was reported by Chardan Capital on Monday, September 20, 2021. The analyst firm set a price target for 3.50 expecting FBRX to rise to within 12 months (a possible 455.56% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Forte Biosciences (NASDAQ: FBRX) is $0.63 last updated March 14, 2024 at 7:38 PM EDT.
There are no upcoming dividends for Forte Biosciences.
Forte Biosciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Forte Biosciences.
Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.